The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis
Open accessAbstract
Objective: To report the clinical, radiological, and immunological association of demyelinating disorders with anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis. Methods: Clinical and radiological analysis was done of a cohort of 691 patients with anti‐NMDAR encephalitis. Determination of antibodies to NMDAR, aquaporin‐4 (AQP4), and myelin oligodendrocyte glycoprotein (MOG) was performed using brain immunohistochemistry and cell‐based assays. Results: Twenty‐three of 691 patients with anti‐NMDAR encephalitis had prominent magnetic resonance imaging (MRI) and/or clinical features of demyelination. Group 1 included 12 patients in whom anti‐NMDAR encephalitis was preceded or followed by independent episodes of neuromyelitis optica (NMO) spectrum disorder (5 cases, 4 anti‐AQP4 positive) or brainstem or multifocal demyelinating syndromes (7 cases, all anti‐MOG positive). Group 2 included 11 patients in whom anti‐NMDAR encephalitis occurred simultaneously with MRI and symptoms compatible with demyelination (5 AQ4 positive, 2 MOG positive). Group 3 (136 controls) included 50 randomly selected patients with typical anti‐NMDAR encephalitis, 56 with NMO, and 30 with multiple sclerosis; NMDAR antibodies were detected only in the 50 anti‐NMDAR patients, MOG antibodies in 3 of 50 anti‐NMDAR and 1 of 56 NMO patients, and AQP4 antibodies in 48 of 56 NMO and 1 of 50 anti‐NMDAR patients (p < 0.0001 for all comparisons with Groups 1 and 2). Most patients improved with immunotherapy, but compared with anti‐NMDAR encephalitis the demyelinating episodes required more intensive therapy and resulted in more residual deficits. Only 1 of 23 NMDAR patients with signs of demyelination had ovarian teratoma compared with 18 of 50 anti‐NMDAR controls (p = 0.011). Interpretation: Patients with anti‐NMDAR encephalitis may develop concurrent or separate episodes of demyelinating disorders, and conversely patients with NMO or demyelinating disorders with atypical symptoms (eg, dyskinesias, psychosis) may have anti‐NMDAR encephalitis. Ann Neurol 2014;75:411–428
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488
Self-citationTitulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165 · cited 2×
“The clinical features of the other 49 patients were typical of anti-NMDAR encephalitis and comparable to those published.(4) Three of these 49 patients had low-titer MOG antibodies, demonstrating that the frequency of these antibodies in this group of patients was also significantly lower than that found in Groups 1 a…”
MethodResultSelf-citationRevised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,574
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Self-citationThe spectrum of neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J., & Weinshenker, B. G. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70216-8 · Cited by 2,179
Gresa-Arribas, N., Titulaer, M. J., Torrents, A., Aguilar, E., McCracken, L., Leypoldt, F., Gleichman, A. J., Balice-Gordon, R., Rosenfeld, M. R., Lynch, D., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70282-5 · Cited by 1,306
Self-citationCellular and synaptic mechanisms of anti-NMDA receptor encephalitis
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., Parsons, T. D., Lynch, D. R., Dalmau, J., & Balice-Gordon, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0167-10.2010 · Cited by 1,143
Self-citationEFNS guidelines on diagnosis and management of neuromyelitis optica
Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illes, Z., Montalban, X., Du Pasquier, R. A., Polman, C. H., Sorensen, P. S., & Hemmer, B. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03066.x · Cited by 461
Mader, S., Gredler, V., Schanda, K., Rostasy, K., Dujmovic, I., Pfaller, K., Lutterotti, A., Jarius, S., Di Pauli, F., Kuenz, B., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-184 · Cited by 449
Self-citationMyelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Kitley, J., Woodhall, M., Waters, P., Leite, M. I., Devenney, E., Craig, J., Palace, J., & Vincent, A. (2012) · Neurology · doi:10.1212/wnl.0b013e31826aac4e · Cited by 445
Kayser, M. S., Titulaer, M. J., Gresa-Arribas, N., & Dalmau, J. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3216 · Cited by 419
Self-citationSelf-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
O'Connor, K. C., McLaughlin, K. A., De Jager, P. L., Chitnis, T., Bettelli, E., Xu, C., Robinson, W. H., Cherry, S. V., Bar-Or, A., Banwell, B., et al. (2007) · Nature Medicine · doi:10.1038/nm1488 · Cited by 416
Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis
Martinez-Hernandez, E., Horvath, J., Shiloh-Malawsky, Y., Sangha, N., Martinez-Lage, M., & Dalmau, J. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c136 · Cited by 375
Self-citationThe spectrum of MOG autoantibody-associated demyelinating diseases
Reindl, M., Di Pauli, F., Rostásy, K., & Berger, T. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.118 · Cited by 375
Self-citationCognitive deficits following anti-NMDA receptor encephalitis
Finke, C., Kopp, U. A., Prüss, H., Dalmau, J., Wandinger, K.-P., & Ploner, C. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300411 · Cited by 351
Self-citationDisrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis
Mikasova, L., De Rossi, P., Bouchet, D., Georges, F., Rogemond, V., Didelot, A., Meissirel, C., Honnorat, J., & Groc, L. (2012) · Brain · doi:10.1093/brain/aws092 · Cited by 341
Brilot, F., Dale, R. C., Selter, R. C., Grummel, V., Reddy Kalluri, S., Aslam, M., Busch, V., Zhou, D., Cepok, S., & Hemmer, B. (2009) · Annals of Neurology · doi:10.1002/ana.21916 · Cited by 322
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis
Pröbstel, A. K., Dornmair, K., Bittner, R., Sperl, P., Jenne, D., Magalhaes, S., Villalobos, A., Breithaupt, C., Weissert, R., Jacob, U., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318228c0b1 · Cited by 306
A population-based study of neuromyelitis optica in Caucasians
Asgari, N., Lillevang, S. T., Skejoe, H. P. B., Falah, M., Stenager, E., & Kyvik, K. O. (2011) · Neurology · doi:10.1212/wnl.0b013e3182190f74 · Cited by 257
Functional and structural brain changes in anti–N‐methyl‐D‐aspartate receptor encephalitis
Finke, C., Kopp, U. A., Scheel, M., Pech, L., Soemmer, C., Schlichting, J., Leypoldt, F., Brandt, A. U., Wuerfel, J., Probst, C., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23932 · Cited by 211
Self-citationAge-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple Sclerosis
McLaughlin, K. A., Chitnis, T., Newcombe, J., Franz, B., Kennedy, J., McArdel, S., Kuhle, J., Kappos, L., Rostasy, K., Pohl, D., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801888 · Cited by 189
Aquaporin-4 antibody–negative neuromyelitis optica: Distinct assay sensitivity–dependent entity
Marignier, R., Bernard-Valnet, R., Giraudon, P., Collongues, N., Papeix, C., Zéphir, H., Cavillon, G., Rogemond, V., Casey, R., Frangoulis, B., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318296e917 · Cited by 170
Jarius, S., Paul, F., Franciotta, D. M., Seze, J. D., Münch, C., Salvetti, M., Ruprecht, K., Liebetrau, M., Wandinger, K. P., Akman‐Demir, G., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511431728 · Cited by 140
NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICA
Kruer, M. C., Koch, T., BOURDETTE, D. N., Chabas, D., Waubant, E. L., Mueller, S. G., Moscarello, M. A., Dalmau, J. O., Woltjer, R. L., & Adamus, G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181dc1a7f · Cited by 104
Self-citationNMDA Receptors, Glial Cells, and Clinical Medicine
Lipton, S. A. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.026 · Cited by 93
NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement
Haruki, H., Sano, Y., Shimizu, F., Omoto, M., Tasaki, A., Oishi, M., Koga, M., Saito, K., Takahashi, T., Nakada, T., et al. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.035 · Cited by 49
Höftberger, R., Sabater, L., Marignier, R., Aboul‐Enein, F., Bernard‐Valnet, R., Rauschka, H., Ruiz, A., Blanco, Y., Graus, F., Dalmau, J. O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079083 · Cited by 48
Self-citationNMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement
春木, 明. (2014) · Medical Entomology and Zoology · Cited by 29
N-Methyl d-aspartate receptor antibody encephalitis associated with myelitis
Pennington, C. M., Livingstone, S., Santosh, C., & Razvi, S. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.02.034 · Cited by 21
Sakamoto, H., Hirano, M., Samukawa, M., Ueno, S., Maekura, S., Fujimura, H., Kuwahara, M., Hamada, Y., Isono, C., Tanaka, K., et al. (2012) · European Neurology · doi:10.1159/000342023 · Cited by 10
Self-citationNMDA receptor encephalitis in the course of recurrent CNS demyelinating disorders: A case report
Yamamoto, M., Kokubun, N., Watanabe, Y., Okabe, R., Nakamura, T., & Hirata, K. (2013) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.53.345 · Cited by 8
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationAntibody-Mediated Encephalitis
Dalmau, J., & Graus, F. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708712 · Cited by 1,329
Self-citationin cooperation with the Neuromyelitis Optica Study Group (NEMOS), Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., Pache, F., Stich, O., Beume, L.-A., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0718-0 · Cited by 899
Self-citationDalmau, J., Armangué, T., Planagumà, J., Radosevic, M., Mannara, F., Leypoldt, F., Geis, C., Lancaster, E., Titulaer, M. J., Rosenfeld, M. R., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30244-3 · Cited by 899
Self-citationMOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Jarius, S., Paul, F., Aktas, O., Asgari, N., Dale, R. C., de Seze, J., Franciotta, D., Fujihara, K., Jacob, A., Kim, H. J., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1144-2 · Cited by 747
Self-citation
Metadata
- Authors
- Titulaer, M. J., Höftberger, R., Iizuka, T., Leypoldt, F., McCracken, L., Cellucci, T., Benson, L. A., Shu, H., Irioka, T., Hirano, M., Singh, G., Cobo Calvo, A., Kaida, K., Morales, P. S., Wirtz, P. W., Yamamoto, T., Reindl, M., Rosenfeld, M. R., Graus, F., Saiz, A., & Dalmau, J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2014-03
- Volume
- 75
- Issue
- 3
- Pages
- 411-428
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1482033427
- Cited by
- 518
- References
- 31
- FWCI
- 26.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.